Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Priyanka Borhade"'
Autor:
Kesia Esther da Silva, Kashmira Date, Nilma Hirani, Christopher LeBoa, Niniya Jayaprasad, Priyanka Borhade, Joshua Warren, Rahul Shimpi, Seth A. Hoffman, Matthew Mikoleit, Pankaj Bhatnagar, Yanjia Cao, Pradeep Haldar, Pauline Harvey, Chenhua Zhang, Savita Daruwalla, Dhanya Dharmapalan, Jeetendra Gavhane, Shrikrishna Joshi, Rajesh Rai, Varsha Rathod, Keertana Shetty, Divyalatha S. Warrier, Shalini Yadav, Debjit Chakraborty, Sunil Bahl, Arun Katkar, Abhishek Kunwar, Vijay Yewale, Shanta Dutta, Stephen P. Luby, Jason R. Andrews
Publikováno v:
mBio, Vol 14, Iss 4 (2023)
ABSTRACT We performed whole-genome sequencing of 174 Salmonella Typhi and 54 Salmonella Paratyphi A isolates collected through prospective surveillance in the context of a phased typhoid conjugate vaccine introduction in Navi Mumbai, India. We invest
Externí odkaz:
https://doaj.org/article/8922c268fb764fc68028d19d64d31659
Autor:
Niniya Jayaprasad, Priyanka Borhade, Christopher LeBoa, Kashmira Date, Shrikrishna Joshi, Rahul Shimpi, Jason R. Andrews, Pankaj Bhatnagar, Stephen P. Luby, Seth A. Hoffman
India has one of the highest estimated burdens of enteric fever globally. Prior to implementation of Typbar-TCV®typhoid conjugate vaccine (TCV) in a public sector pediatric immunization campaign in Navi Mumbai, India, we conducted a retrospective re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72b498d7e49396908798c2edefee7337
https://doi.org/10.1101/2023.05.27.23290637
https://doi.org/10.1101/2023.05.27.23290637
Autor:
Kesia Esther Da Silva, Kashmira Date, Nilma Hirani, Christopher LeBoa, Niniya Jayaprasad, Priyanka Borhade, Joshua Warren, Rahul Shimpi, Seth Ari Sim-Son Hoffman, Matthew Mikoleit, Pankaj Bhatnagar, Yanjia Cao, Shanta Dutta, Stephen P Luby, Jason R. Andrews
We performed whole genome sequencing of 174SalmonellaTyphi and 54SalmonellaParatyphi A isolates collected through prospective and retrospective surveillance in the context of a phased typhoid conjugate vaccine introduction in Navi Mumbai, India. We i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0daf9b036b532335585c9115d8d3fb84
https://doi.org/10.1101/2023.02.23.23286256
https://doi.org/10.1101/2023.02.23.23286256
Autor:
Seth A. Hoffman, Christopher LeBoa, Kashmira Date, Pradeep Haldar, Pauline Harvey, Rahul Shimpi, Qian An, Chenhua Zhang, Niniya Jayaprasad, Lily Horng, Kirsten Fagerli, Priyanka Borhade, Debjit Chakraborty, Sunil Bahl, Arun Katkar, Abhishek Kunwar, Vijay Yewale, Jason R. Andrews, Pankaj Bhatnagar, Shanta Dutta, Stephen P. Luby
BackgroundThe WHO recommends vaccines for prevention and control of typhoid fever, especially where antimicrobial-resistant typhoid circulates. In 2018 the Navi Mumbai Municipal Corporation (NMMC), implemented a TCV campaign. The campaign targeted al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b504900d03f628b6d09305476cc80c56
https://doi.org/10.1101/2022.10.26.22281529
https://doi.org/10.1101/2022.10.26.22281529